Study provides new evidence of weight loss benefits for type 2 diabetes patients

Researchers in the School of Population Health at RCSI University of Medicine and Health Sciences have provided new evidence of the health benefits of weight loss efforts that lead to diabetes remission for type 2 diabetes patients.

Ipsen FOP treatment refused authorisation by EC

Ipsen’s palovarotene is intended to treat fibrodysplasia ossificans progressiva. Credit: Ipsen Pharma. The European Commission (EC) has refused to grant marketing authorisation for Ipsen’s investigational therapy,

July 20, 2023

A 988 operator, faced with a flood of calls, turns to AI to boost counselor skills

Over 1,000 times a day, distressed people call crisis support lines operated by Protocall Services. Its counselors are carefully trained for the sensitive and taxing

June 22, 2023

CDC Tells Docs to Be on the Lookout for Bird Flu Cases

The CDC wants clinicians and health departments to consider potential infections with the highly pathogenic avian influenza (HPAI) A(H5N1) virus, commonly known as bird flu,

April 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.